ICD Co Ltd
KOSDAQ:040910
P/FCFE
Price to FCFE
Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.
Market Cap | P/FCFE | ||||
---|---|---|---|---|---|
KR |
I
|
ICD Co Ltd
KOSDAQ:040910
|
149.9B KRW | -9.1 | |
NL |
ASML Holding NV
AEX:ASML
|
332.4B EUR | 98.4 | ||
US |
Applied Materials Inc
NASDAQ:AMAT
|
172.5B USD | 23.2 | ||
US |
Lam Research Corp
NASDAQ:LRCX
|
119.4B USD | 27.9 | ||
JP |
Tokyo Electron Ltd
TSE:8035
|
16.8T JPY | 63 | ||
US |
KLA Corp
NASDAQ:KLAC
|
96.6B USD | 27 | ||
JP |
Disco Corp
TSE:6146
|
5.4T JPY | 76.4 | ||
NL |
ASM International NV
AEX:ASM
|
30.2B EUR | 96.3 | ||
JP |
Advantest Corp
TSE:6857
|
3.8T JPY | 199.8 | ||
JP |
Lasertec Corp
TSE:6920
|
3.8T JPY | 144.8 | ||
CN |
NAURA Technology Group Co Ltd
SZSE:002371
|
164.9B CNY | 378.8 |
P/FCFE Forward Multiples
Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.